FBXO31 is down-regulated and may function as a tumor suppressor in hepatocellular carcinoma

Oncology Reports

Volumn 24, Issue 3, 2010, Pages 715-720

  Huang, Hai Li ^a   Zheng, Wen Ling ^a   Zhao, Rui ^a   Zhang, Bao ^a   Ma, Wen Li ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Down regulation; FBXO31; Hepatocellular carcinoma

Indexed keywords

CYCLIN D1; F BOX PROTEIN; F BOX PROTEIN 31; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE REGULATION; CELL PROLIFERATION; COLONY FORMATION; CYTOPLASM; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING;

CARCINOMA, HEPATOCELLULAR; CELL CYCLE; CELL PROLIFERATION; CYCLIN D1; DOWN-REGULATION; F-BOX PROTEINS; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECOMBINANT FUSION PROTEINS; TIME FACTORS; TRANSFECTION; TUMOR SUPPRESSOR PROTEINS; UBIQUITINATION;

EID: 77956307171     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000912     Document Type: Article

References (28)

1. Bai C, Sen P, Hofmann K, Ma L, Goebl M, Harper JW and Elledge SJ: SKP1 connects cell cycle regulators to the ubiquitin proteolysis machinery through a novel motif, the F-box. Cell 86: 263-274, 1996.
2. Hochstrasser M: Ubiquitin-dependent protein degradation. Annu Rev Genet 30: 405-439, 1996.
3. Skowyra D, Craig KL, Tyers M, Elledge SJ and Harper JW: F-box proteins are receptors that recruit phosphorylated substrates to the SCF ubiquitin-ligase complex. Cell 91: 209-219, 1997.
4. Ho MS, Tsai PI and Chien CT: F-box proteins: the key to protein degradation. J Biomed Sci 13: 181-191, 2006.
5. Winston JT, Koepp DM, Zhu C, Elledge SJ and Harper JW: A family of mammalian F-box proteins. Curr Biol 9: 1180-1182, 1996.
6. Cenciarelli C, Chiaur DS, Guardavaccaro D, Parks W, Vidal M and Pagano M: Identification of a family of human F-box proteins. Curr Biol 9: 1177-1179, 1999. (Pubitemid 29527103)
7. Jin J, Cardozo T, Lovering RC, Elledge SJ, Pagano M and Harper JW: Systematic analysis and nomenclature of mammalian F-box proteins. Genes Dev 18: 2573-2580, 2004.
8. Kipreos ET and Pagano M: The F-box protein family. Genome Biol 1: Reviews3002, 2000.
9. Kumar R, Neilsen PM, Crawford J, et al: FBXO31 is the chromosome 16q24.3 senescence gene, a candidate breast tumor suppressor, and a component of an SCF complex. Cancer Res 65: 11304-11313, 2005.
10. Santra MK, Wajapeyee N and Green MR: F-box protein FBXO31 mediates cyclin D1 degradation to induce G1 arrest after DNA damage. Nature 459: 722-725, 2009.
11. Wang ZC, Lin M, Wei LJ, Li C, Miron A, Lodeiro G, Harris L, Ramaswamy S, Tanenbaum DM, Meyerson M, Iglehart JD and Richardson A: Loss of heterozygosity and its correlation with expression profiles in subclasses of invasive breast cancers. Cancer Res 64: 64-71, 2004.
12. Bais AJ: FBXO31 (F-box protein 31). Atlas Genet Cytogenet Oncol Haematol, June 2008. URL: http://AtlasGenetics Oncology.org/Genes/FBXO31ID44280ch16q24. html
13. Resnitzky D, Gossen M, Bujard H and Reed SI: Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system. Mol Cell Biol 14: 1669-1679, 1994. (Pubitemid 24074562)
14. Diehl JA, Cheng M, Roussel MF and Sherr CJ: Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization. Genes Dev 12: 3499-3511, 1998.
15. Nakayama K, Nagahama H, Minamishima YA, et al: Targeted disruption of Skp2 results in accumulation of cyclin E and p27Kip1, polyploidy and centrosome overduplication. EMBO J 19: 2069-2081, 2000.
16. Ganoth D, Bornstein G, Ko TK, et al: The cell-cycle regulatory protein Cks1 is required for SCFSkp2-mediated ubiquitinylation of p27. Nat Cell Biol 3: 321-324, 2001. (Pubitemid 32201330)
17. Skp2-dependent ubiquitylation. Proc Natl Acad Sci USA 100: 10231-10236, 2003.
18. Tedesco D, Lukas J and Reed SI: The pRb-related protein p130 is regulated by phosphorylation-dependent proteolysis via the protein-ubiquitin ligase SCFSkp2. Genes Dev 16: 2946-2957, 2002.
19. Hiramatsu Y, Kitagawa K, Suzuki T, et al: Degradation of Tob1 mediated by SCFSkp2-dependent ubiquitination. Cancer Res 66: 8477-8483, 2006.
20. von der Lehr N, Johansson S, Wu S, et al: The F-box protein Skp2 participates in c-Myc proteosomal degradation and acts as a cofactor for c-Myc-regulated transcription. Mol Cell 11: 1189-1200, 2003.
21. Imaki H, Nakayama K, Delehouzee S, et al: Cell cycle-dependent regulation of the Skp2 promoter by GA-binding protein. Cancer Res 63: 4607-4613, 2003. (Pubitemid 36951037)
22. Yokoi S, Yasui K, Saito-Ohara F, et al: A novel target gene, SKP2, within the 5p13 amplicon that is frequently detected in small cell lung cancers. Am J Pathol 161: 207-216, 2002.
23. Kanei-Ishii C, Nomura T, Takagi T, Watanabe N, Nakayama KI and Ishii S: Fbxw7 acts as an E3 ubiquitin ligase that targets c-Myb for nemo-like kinase (NLK)-induced degradation. J Biol Chem 283: 30540-30548, 2008.
24. Kitagawa K, Hiramatsu Y, Uchida C, et al: Fbw7 promotes ubiquitin-dependent degradation of c-Myb: involvement of GSK3-mediated phosphorylation of Thr-572 in mouse c-Myb. Oncogene 28: 2393-2405, 2009.
25. Wu G, Lyapina S, Das I, et al: SEL-10 is an inhibitor of notch signaling that targets notch for ubiquitin-mediated protein degradation. Mol Cell Biol 21: 7403-7415, 2001.
26. Mao JH, Kim IJ, Wu D, et al: FBXW7 targets mTOR for degradation and cooperates with PTEN in tumor suppression. Science 321: 1499-1502, 2008.
27. FBW7 ubiquitin ligase complex as a tumor suppressor in T cell leukemia. J Exp Med 204: 1825-1835, 2007.
28. Onoyama I, Tsunematsu R, Matsumoto A, et al: Conditional inactivation of Fbxw7 impairs cell-cycle exit during T cell differentiation and results in lymphomatogenesis. J Exp Med 204: 2875-2888, 2007.